Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation — Stella

Home/Liver Transplant Failure/Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation

View on ClinicalTrials.gov

Recruiting

Back to Liver Transplant Failure trials

Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation

Trial locations(1 site)

Belgium

Xavier Verhelst, Ghent, Flanders

Key details

Sponsor

University Hospital, Ghent

Collaborators

Fund for Scientific Research, Flanders, Belgium, University Hospital, Antwerp

Enrollment target

~600 participants

Started

April 2023

Primary completion

April 2026

Age range

18 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.